Person Dr Hayley Ramshaw National Health and Medical Research Council Viewed: [[ro.stat.viewed]] Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A newly identified role for 14-3-3zeta protein in thrombosis and platelet procoagulant activity (funded by National Health and Medical Research Council) Participant in Dissecting the role of the IL-3 receptor alpha subunit and beta-catenin in Acute Myeloid Leukaemia (funded by National Health and Medical Research Council) Principal investigator of Does CD123 provide a biological advantage to leukaemia stem cells? (funded by National Health and Medical Research Council) Participant in Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target (funded by National Health and Medical Research Council) Participant in Mab immunotherapies for myeloid leukemia patients with germline or somatic RUNX1 mutations. (funded by National Health and Medical Research Council) View all 6 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover Saved to MyRDA Save to MyRDA
Click to explore relationships graph Help Related Grants and Projects $relation_to_title = []; $dupes = 0;?> Participant in A newly identified role for 14-3-3zeta protein in thrombosis and platelet procoagulant activity (funded by National Health and Medical Research Council) Participant in Dissecting the role of the IL-3 receptor alpha subunit and beta-catenin in Acute Myeloid Leukaemia (funded by National Health and Medical Research Council) Principal investigator of Does CD123 provide a biological advantage to leukaemia stem cells? (funded by National Health and Medical Research Council) Participant in Interleukin-3 receptor signaling is a driver of myeloid leukaemia and a significant therapeutic target (funded by National Health and Medical Research Council) Participant in Mab immunotherapies for myeloid leukemia patients with germline or somatic RUNX1 mutations. (funded by National Health and Medical Research Council) View all 6 related grants and projects User Contributed Tags Login to tag this record with meaningful keywords to make it easier to discover